BPC-157 / Thymosin Beta 4 Fragment 17-23 (10MG / 50MG)
€320.00
BPC-157 / Thymosin Beta 4 Fragment 17-23 (10MG / 50MG) is a peptide combination studied for its potential in tissue regeneration, muscle recovery, and anti-inflammatory support. Research suggests it may aid in wound healing, fibrosis prevention, and cardiovascular health, making it a key focus in regenerative medicine studies.
✓ Fast delivery
✓ Premium quality
✓ 3th party tested
In Stock
CompareDescription
BPC-157 / Thymosin Beta 4 Fragment 17-23 (10MG / 50MG) Product Information
Molecular Formula:
- BPC-157: C62H98N16O22
- Thymosin Beta 4 Fragment 17-23: C12H21N3O3
Molecular Weight:
- BPC-157: 1419.5 g/mol
- Thymosin Beta 4 Fragment 17-23: 255.3 g/mol
Synonyms
- BPC-157: Bepecin, PL-14736, Pentadecapeptide BPC-157
- Thymosin Beta 4 Fragment 17-23: Ac-SDKP
Research Applications:
- Tissue regeneration and healing
- Muscle and tendon recovery
- Anti-inflammatory properties
- Neurological support
- Cardiovascular health
What is BPC-157?
BPC-157 is a synthetic peptide derived from a protein found in gastric juices, known for its potential in tissue repair, anti-inflammatory properties, and regenerative effects. Research has shown that BPC-157 promotes angiogenesis (formation of new blood vessels), accelerates wound healing, and supports recovery from muscle and tendon injuries. Studies have also explored its effects on gut health, neuroprotection, and cardiovascular function.
What is Thymosin Beta 4 Fragment 17-23?
Thymosin Beta 4 (Tβ4) is a naturally occurring peptide involved in cell migration, tissue regeneration, and wound healing. The Fragment 17-23 of Tβ4, also known as Ac-SDKP, is recognized for its ability to modulate immune responses, reduce fibrosis, and support cardiovascular health. Research suggests that Ac-SDKP plays a role in tissue remodeling and may protect against heart and kidney fibrosis.
BPC-157 and Tissue Regeneration
Studies have demonstrated BPC-157’s ability to enhance tissue healing, including muscles, tendons, and ligaments. In rodent models, BPC-157 accelerated wound closure, improved blood vessel formation, and reduced inflammation in injured tissues. Researchers are investigating its applications in sports medicine and recovery from injuries.
Thymosin Beta 4 Fragment 17-23 and Anti-Fibrotic Effects
Ac-SDKP, the active fragment of Thymosin Beta 4, has been studied for its role in preventing fibrosis (excessive tissue scarring). Research suggests that it regulates inflammatory responses and reduces the formation of scar tissue in organs such as the heart and kidneys. This has led to interest in its potential use in cardiovascular and renal disease research.
Combined Benefits of BPC-157 and Thymosin Beta 4 Fragment 17-23
By combining BPC-157 with Thymosin Beta 4 Fragment 17-23, researchers aim to explore a synergistic effect on tissue repair and anti-inflammatory responses. The combination has been studied for its potential applications in regenerative medicine, injury recovery, and chronic inflammatory conditions.
Legal Disclaimer
This product is sold as a pure compound for research purposes only and is not meant for use as a dietary supplement. Please refer to our terms and conditions prior to purchase.
Safety Information
Keep this product out of the reach of children. Limited research is available on BPC-157 and Thymosin Beta 4 Fragment 17-23, and improper handling may result in unintended effects. This peptide combination is not a dietary supplement and is intended solely for laboratory research.
We ensure the quality and description of all products but are not responsible for improper usage.
The content provided on this website is for informational and educational purposes only. These peptides have not been evaluated by the FDA and are not intended for diagnosing, preventing, or treating any medical condition.
